Molecular and Metabolic Imaging in Multiple Sclerosis

Publication date: May 2017
Source:Neuroimaging Clinics of North America, Volume 27, Issue 2
Author(s): Marcello Moccia, Olga Ciccarelli

Teaser

Multiple sclerosis is a multifactorial disease with heterogeneous pathogenetic mechanisms, which deserve to be studied to evaluate new possible targets for treatments and improve patient management. MR spectroscopy and PET allow assessing in vivo the molecular and metabolic mechanisms underlying the pathogenesis of multiple sclerosis. This article focuses on the relationship between these imaging techniques and the biologic and chemical pathways leading to multiple sclerosis pathology and its clinical features. Future directions of research are also presented.


http://ift.tt/2nsw7Nu